Measurement of in vivo therapeutic mAb concentrations: comparison of conventional serum/plasma collection and analysis to dried blood spot sampling

Preclinical bridging studies: understanding dried blood spot and plasma exposure profiles

(2013) Enaksha R Wickremsinhe et al.   Bioanalysis

Evaluation of dried blood spots for the quantification of therapeutic monoclonal antibodies and detection of anti-drug antibodies

(2013) Kerstin Kaendler et al.   Bioanalysis

Validation of a Ligand Binding Assay Using Dried Blood Spot Sampling

(2012) Daniel Burns et al.   AAPS Journal

Managing the effect of hematocrit on DBS analysis in a regulated environment

(2012) Leimin Fan et al.   Bioanalysis

EBF recommendation on the validation of bioanalytical methods for dried blood spots

(2011) Philip Timmerman et al.   Bioanalysis

Thinking about dried blood spots for pharmacokinetic assays and therapeutic drug monitoring

(2011) Peter T Kissinger   Bioanalysis

Combination of ELISA and dried blood spot technique for the quantification of large molecules using exenatide as a model

(2011) Yong-Qing Lin et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

Evaluation of dry blood spot technique for quantification of an Anti-CD20 monoclonal antibody drug in human blood samples

(2011) Yong-Qing Lin et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

Cytomegalovirus antibodies in dried blood spots: a minimally invasive method for assessing stress, immune function, and aging

(2011) Jennifer B Dowd et al.   Immunity & Ageing

Pharmacokinetic considerations as to when to use dried blood spot sampling

(2010) Gary Emmons et al.   Bioanalysis

Assessment of DBS technology for the detection of therapeutic antibodies

(2010) Peter J Prince et al.   Bioanalysis

Dried Blood Spot Methods in Therapeutic Drug Monitoring: Methods, Assays, and Pitfalls

(2009) Peter M Edelbroek et al.   THERAPEUTIC DRUG MONITORING